{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262943941828736.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jinorgbio.2017.07.002"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0162013416304743?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0162013416304743?httpAccept=text/plain"}}],"dc:title":[{"@value":"Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262943941828737","@type":"Researcher","foaf:name":[{"@value":"Weiwei Hu"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943941828864","@type":"Researcher","foaf:name":[{"@value":"Lei Fang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943941828736","@type":"Researcher","foaf:name":[{"@value":"Wuyang Hua"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943941828738","@type":"Researcher","foaf:name":[{"@value":"Shaohua Gou"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01620134"}],"prism:publicationName":[{"@value":"Journal of Inorganic Biochemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-10","prism:volume":"175","prism:startingPage":"47","prism:endingPage":"57"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0162013416304743?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0162013416304743?httpAccept=text/plain"}],"createdAt":"2017-07-04","modifiedAt":"2025-06-21","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360283690810870400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Chemical synthesis of an indomethacin ester prodrug and its metabolic activation by human carboxylesterase 1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855122859520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Water-Soluble Small Molecule Boron Carrier Targeting Biotin Receptors for Neutron Capture Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367085358720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual-action Pt(Ⅳ) prodrugs and targeted delivery in metal-organic frameworks : overcoming cisplatin resistance and improving anticancer activity"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jinorgbio.2017.07.002"},{"@type":"CROSSREF","@value":"10.1246/bcsj.20220218_references_DOI_YoCuthmbR8hyw52faz4nMpgSaMo"},{"@type":"CROSSREF","@value":"10.1021/acsomega.4c09388_references_DOI_YoCuthmbR8hyw52faz4nMpgSaMo"},{"@type":"CROSSREF","@value":"10.1016/j.bmcl.2018.02.035_references_DOI_YoCuthmbR8hyw52faz4nMpgSaMo"}]}